HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma | Zendy

Fuqiang Wang | Zendy; HuiLi Yang | Zendy; Zhigang Deng | Zendy; Yongjie Su | Zendy; Qinliang Fang | Zendy; Zhenyu Yin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma

Author(s) -

Fuqiang Wang,

HuiLi Yang,

Zhigang Deng,

Yongjie Su,

Qinliang Fang,

Zhenyu Yin

Publication year - 2016

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000452545

Subject(s) - gene knockdown , hepatocellular carcinoma , cancer research , carcinogenesis , cell growth , biology , in vivo , apoptosis , in vitro , long non coding rna , cell , cancer , downregulation and upregulation , gene , genetics

Recent studies reveal that long non-coding RNAs (LncRNAs) play critical roles in the proliferation and migration of human cancer. Previous report has shown that LncRNA HOXA-AS2 was involved in carcinoma processes. However, the expression and biological function of HOXA-AS2 in hepatocellular carcinoma (HCC) are poorly understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research